Chemours Company Overview
Chemours Company Target Price
Analysts' 12-month price predictions for CC.
Share Price
$11.68
Average Target Price
$16.00
37% upside
37% upside2 analysts in the last 4 months
High: $17 | Low: $15
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2025-05-07 | UBSJoshua Spector | $17 | 45.5% upside |  |
| 2025-04-15 | Mizuho SecuritiesJohn Roberts | $15 | 28.4% upside | |
| 2024-10-11 | RBC CapitalArun Viswanathan | $28 | 139.7% upside | |
| 2024-10-07 | BMO CapitalJohn McNulty | $32 | 174% upside | |
| 2024-08-06 | BMO CapitalJohn McNulty | $30 | 156.8% upside | |
| 2024-06-07 | Mizuho SecuritiesJohn Roberts | $25 | 114% upside | |
| 2024-05-29 | UBSRich Hilliker | $31 | 165.4% upside | |
| 2024-04-09 | BMO CapitalJohn McNulty | $34 | 191.1% upside | |
| 2024-04-01 | UBSJoshua Spector | $28 | 139.7% upside | |
| 2024-04-01 | CFRAEmily Nassedd Mitsch | $18 | 54.1% upside | |
| 2024-03-13 | D.A. DavidsonLinda Bolton Weiser | $24 | 105.5% upside | |
| 2023-12-01 | RBC CapitalArun Viswanathan | $40 | 242.5% upside | |
| 2023-10-30 | Morgan StanleyVincent Andrews | $33 | 182.5% upside | |
| 2023-01-10 | RBC CapitalArun Viswanathan | $33 | 182.5% upside | |
| 2022-05-04 | RBC Capital | $48 | 311% upside | |
| 2021-05-20 | Bank of America SecuritiesMatthew DeYoe | $42 | 259.6% upside | |
| 2021-05-10 | Morgan StanleyVincent Andrews | $35 | 199.7% upside | |
| 2021-05-06 | Argus ResearchDavid Coleman | $40 | 242.5% upside | |